Literature DB >> 19082419

Conditioned place preference induced by licit drugs: establishment, extinction, and reinstatement.

Yu Liu1, Bernard Le Foll, Yanli Liu, Xi Wang, Lin Lu.   

Abstract

The conditioned place preference (CPP) model has been widely used to evaluate the rewarding effects of abused drugs, and recently, the extinction and reinstatement phases of this paradigm have been used to assess relapse to drug seeking. The vast majority of studies have focused on CPP induced by illicit drugs, such as psychostimulants and opioids. Although legal psychoactive drugs, such as ethanol, nicotine, and caffeine, are more widely used than illegal drugs, the establishment, extinction, and reinstatement of CPP produced by these licit drugs are less well understood. The present review discusses the extant research on CPP induced by legal drugs. We first describe the CPP model and discuss the behavioral procedures used to induce CPP for ethanol, nicotine, and caffeine. We then summarize the neuronal substrates that underlie CPP induced by these drugs from a genetic perspective. Finally, we draw on findings from pharmacological studies and discuss the neurotransmitters and neurohormones underlying CPP produced by ethanol, nicotine, and caffeine.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19082419      PMCID: PMC5848638          DOI: 10.1100/tsw.2008.154

Source DB:  PubMed          Journal:  ScientificWorldJournal        ISSN: 1537-744X


  18 in total

1.  Hippocampal and Insular Response to Smoking-Related Environments: Neuroimaging Evidence for Drug-Context Effects in Nicotine Dependence.

Authors:  F Joseph McClernon; Cynthia A Conklin; Rachel V Kozink; R Alison Adcock; Maggie M Sweitzer; Merideth A Addicott; Ying-hui Chou; Nan-kuei Chen; Matthew B Hallyburton; Anthony M DeVito
Journal:  Neuropsychopharmacology       Date:  2015-07-16       Impact factor: 7.853

Review 2.  Modeling relapse in animals.

Authors:  Rémi Martin-Fardon; Friedbert Weiss
Journal:  Curr Top Behav Neurosci       Date:  2013

3.  Involvement of insular muscarinic cholinergic receptors in morphine-induced conditioned place preference in rats.

Authors:  Wei Wu; Hui Li; Yu Liu; Xinjie Huang; Lei Chen; Haifeng Zhai
Journal:  Psychopharmacology (Berl)       Date:  2014-04-04       Impact factor: 4.530

4.  Effect of yohimbine stress on reacquisition of oxycodone seeking in rats.

Authors:  Amanda T Campbell; Daniela Kwiatkowski; Emily Boughner; Francesco Leri
Journal:  Psychopharmacology (Berl)       Date:  2012-01-18       Impact factor: 4.530

5.  Abuse Liability, Anti-Nociceptive, and Discriminative Stimulus Properties of IBNtxA.

Authors:  Ariful Islam; Mohammad Atiqur Rahman; Megan B Brenner; Allamar Moore; Alyssa Kellmyer; Harley M Buechler; Frank DiGiorgio; Vincent R Verchio; Laura McCracken; Mousumi Sumi; Robert Hartley; Joseph R Lizza; Gustavo Moura-Letts; Bradford D Fischer; Thomas M Keck
Journal:  ACS Pharmacol Transl Sci       Date:  2020-07-27

6.  Understanding Addiction Using Animal Models.

Authors:  Brittany N Kuhn; Peter W Kalivas; Ana-Clara Bobadilla
Journal:  Front Behav Neurosci       Date:  2019-11-29       Impact factor: 3.558

7.  Effects of prenatal immune activation and peri-adolescent stress on amphetamine-induced conditioned place preference in the rat.

Authors:  Neil M Richtand; Rebecca Ahlbrand; Paul S Horn; Brad Chambers; Jon Davis; Stephen Benoit
Journal:  Psychopharmacology (Berl)       Date:  2012-07       Impact factor: 4.530

Review 8.  Dopamine D4 receptors in psychostimulant addiction.

Authors:  Patricia Di Ciano; David K Grandy; Bernard Le Foll
Journal:  Adv Pharmacol       Date:  2014

9.  Prime-, stress-, and cue-induced reinstatement of extinguished drug-reinforced responding in rats: cocaine as the prototypical drug of abuse.

Authors:  Patrick M Beardsley; Keith L Shelton
Journal:  Curr Protoc Neurosci       Date:  2012

10.  Taok2 controls behavioral response to ethanol in mice.

Authors:  D Kapfhamer; S Taylor; M E Zou; J P Lim; V Kharazia; U Heberlein
Journal:  Genes Brain Behav       Date:  2012-08-31       Impact factor: 3.449

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.